Moreover, Kreiter et al. have also shown that CD4+ response is crucial for effective anti-B16 immunity in mice after vaccination with tumor antigens, while CD8+ cells can be depleted without a noticeable effect on tumor rejection [18]. This evidence concerns the gene CD4 and neoplasm.